2 Significant events and transactions during the reporting period

The financial position and performance of the group were particularly affected by the following events and transactions during the reporting period:

• On April 16, 2026, the Annual General Meeting approved an ordinary dividend of CHF 0.10 per share to be paid out of reserves (2025: CHF 0.50 per share). For more details, refer to note 8.
• In the first half of 2026, the group repaid CHF 7.0 million under the syndicated revolving credit facility. As of June 30, 2026, the facility was undrawn, compared to a drawdown of CHF 7.0 million as of December 31, 2025. For more details, refer to note 9.
• In 2023, the group announced its intention to sell its Polish entity, medmix Poland, following the decision not to resume operations in Wroclaw, Poland. That same year, the group entered into a contractual agreement with the buyer of the former subsidiary, medmix Poland, establishing a minimum net equity after the sale of all company assets (net equity guarantee). The group assessed the risk associated with the net equity guarantee based on the most likely outcome and recognized a provision. As of June 30, 2026, the provision for the net equity guarantee amounted to CHF 3.0 million (December 31, 2025: CHF 3.0 million).
  
  In 2024, the buyer of the former subsidiary medmix Poland sued the group regarding payment for machines purchased from the former subsidiary to be deployed in the new factory in Valencia. It was contractually agreed that part of the purchase price would be offset against existing loans owed by the former subsidiary, medmix Poland, to the group. In accordance with the contractual arrangements, the purchase price and the outstanding loan receivables were offset, resulting in a residual "Other current liability" of CHF 0.4 million (December 31, 2025: CHF 0.4 million). The buyer subsequently disputed the appropriateness of this offset.
  
  In March 2026, a court ruling in Poland determined that the existing loans and the purchase price of the machines could not be offset. This ruling means that the loan receivable from the former subsidiary and the purchase price of the machines must be presented on a gross basis in the balance sheet, rather than on a net basis. Consequently, "Other current receivables and prepaid expenses" on the asset side and "Other current and accrued liabilities" on the liabilities side increased by CHF 13.1 million.
  
  The group believes the first-instance decision is incorrect and plans to file an appeal. The ruling is not enforceable, as the appeal period is still ongoing, with proceedings expected to take another 12 to 18 months.
• During the interim period, the group initiated the process of reclaiming U.S. tariffs and expects initial reimbursements to occur in the second half of 2026. As of June 30, 2026, the group has submitted claims totaling CHF 6.8 million, of which CHF 0.3 million has already been received during the interim period, with CHF 0.0 million recognized as interest income (December 31, 2025: claims submitted CHF 0.0 million, 2025: reimbursements received CHF 0.0 million).
  
  Based on the information available and external advice obtained, management considers an inflow of economic benefits not to be virtually certain. As the submitted claims remain under review by the relevant authorities as of June 30, 2026, significant uncertainty exists regarding the recoverability of the remaining CHF 6.6 million. Accordingly, no receivable has been recognized at the reporting date.
  
  Management assessed the submitted claims as a contingent asset because realization is not considered virtually certain as of the reporting date. No contingent assets relating to tariff reclaims were disclosed previously.
• As part of the Growth and Efficiency program, the group recognized restructuring costs of CHF 3.8 million (half-year 2025: CHF 1.0 million), primarily related to restructuring measures initiated at the Beauty site in Bechhofen, Germany, and the dispenser business at the Industry site in Hungerford, UK. Associated with the restructuring initiatives, the group further recorded impairments of production machines and facilities, and other intangible assets totaling CHF 2.6 million (half-year 2025: CHF 0.1 million). For more details, refer to note 5.

For a detailed discussion about the group’s performance and financial position, refer to Financial review section.